期刊文献+

胆囊癌组织鼠类肉瘤病毒癌基因突变与其临床病理特征及预后的关系 被引量:2

The relationship between K- ras gene mutation with clinicopathological and prognosis in gallbladder carcinoma
原文传递
导出
摘要 目的探讨胆囊癌组织中鼠类肉瘤病毒癌基因(K-ras)突变及其与临床病理特征和生存预后的相关性。方法收集胆囊癌手术患者79例,提取胆囊癌组织DNA,采用纳米探针检测K-ras基因第12、13位点密码子突变,分析K-ras基因突变与临床病理特征的相关性,并分析K-ras基因突变对胆囊癌患者预后的影响。结果79例胆囊癌患者中K-ras基因突变率为63.3%(50/79),K-ras突变与临床分期、转移明显相关(P=0.003、0.000)。生存分析结果显示K-ras基因突变组1年、2年无瘤生存率为67.9%、11.5%,野生组为88.3%、43.4%,差异均有统计学意义(P=0.047、0.009);K-ras基因突变组1年、2年总生存率为90.4%、43.0%,野生组为96.3%、70.6%,1年总生存率比较差异无统计学意义,2年总生存率比较差异有统计学意义(P=0.044)。结论K-ras基因突变与胆囊癌的转移、不良预后明显相关。 Objective To investigate the mutation of K-ras gene in gallbladder cancer and its correlation with clinicopathological and prognosis.MethodsDNA from 79 gallbladder cancer who underwent curative resection. The mutation of K-ras gene codon 12 and 13 were detected by nano capture probe. To analyze the correlation between K-ras gene mutation and clinical and pathological indexes. The significance of K-ras gene mutation on the prognosis of patients with gallbladder carcinoma were also be analyzed.ResultsThe total K-ras mutation rate of 79 gallbladder cancer patients was 63.3% (50/79). There were significant correlation between K-ras gene mutation and clinical stages and metastasis (P=0.003, P=0.000). The cumulative one-year and two-year actuarial recurrence free survival rates of patients with K-ras mutation were 67.9% and 11.5%, and the cumulative one-year and two-year actuarial recurrence free survival rates of of patients with wild genotype were 88.3% and 43.4%, the differences are statistically significant(P=0.047, P=0.009). The cumulative one-year and two-year overall survival rate of patients with K-ras mutation were 90.4% and 43.0%, The cumulative one-year and two-year overall survival rate of patients with K-ras wild genotype were 96.3% and 70.6%. there was no difference in statistics in cumulative one-year overall survival rate and with a statistically significant difference in cumulative two-year overall survival rate (P=0.044).ConclusionThe mutation of K-ras gene is significantly related to tumor metastasis and poor prognosis in gallbladder cancer.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2018年第1期130-132,共3页 Chinese Journal of Experimental Surgery
基金 嘉兴市公益性应用技术研究计划(2016AY23053)
关键词 鼠类肉瘤病毒癌基因突变 胆囊癌 预后 K-ras mutation Gallbladder carcinoma Prognosis
  • 相关文献

参考文献5

二级参考文献65

  • 1Fang-Hua Li,Zhuang-Hua Li,Hui-Yan Luo,Miao-Zhen Qiu,Yu-Hong Li,Rui-Hua Xu,State Key Laboratory of Oncology in Southern China,Department of Medical Oncology,Sun YatSen University Cancer Center,Guangzhou 510060,Guangdong Province,China Fang-Hua Li,Department of Medical Oncology,Shengli Oil Field Central Hospital,Dongying 257034,Shandong Province,China Lin Shen,Department of GI Oncology,Peking University School of Oncology,Beijing Cancer Hospital and Institute,Beijing 100142,China Hui-Zhong Zhang,State Key Laboratory of Oncology in Southern China,Department of Pathology,Sun Yat-Sen University Cancer Center,Guangzhou 510060,Guangdong Province,China.Impact of KRAS mutation and PTEN expression on cetuximab-treated colorectal cancer[J].World Journal of Gastroenterology,2010,16(46):5881-5888. 被引量:9
  • 2高枫,唐卫中,李卫.中国人散发性大肠癌K-ras基因突变的研究[J].中华实验外科杂志,2005,22(1):65-67. 被引量:22
  • 3乌新林,王占民,马道新,杨凤辉,孙建芝.外源野生型p53基因对人胆囊癌GBC-SD细胞生长的作用[J].中华实验外科杂志,2005,22(12):1477-1479. 被引量:4
  • 4韩本立,陈耿.胆道外科实验研究的方向与展望[J].中华实验外科杂志,2006,23(8):905-907. 被引量:3
  • 5Gibson WM. Can personalized medicine survive. Can FamPhysician, 1971,17:29-88.
  • 6Langreth R, Waldholz M. New era of personalized medicine:targeting drugs for each unique genetic profile. Oncologist, 1999 ,4:426-427.
  • 7Meyer UA. Genotype or phenotype: the definition of apharmaoogenetic polymorphism. Pharmacogenetics, 1991 , 1 : 66-67.
  • 8Maitland ML,Vasisht K’Ratain MJ. TPMT,UGTiAl and DPYD:genotyping to ensure safer cancer therapy . Trends Pharmacol Sci,2006,27:432437.
  • 9Tam IY, Chung LP, Suen WS, el a]. Distinct epidermal growthfactor receptor and KRAS mutation patterns in non-small cell lungcancer patients with different tobacco exposure andclinicopathologio features. Clin Cancer Res ,2006,12 : 1647-1653.
  • 10Ahmad El,Gawish HH,Al Azizi NM,et al. The prognostic impaclof K-RAS mutations in adult acute myeloid leukemia palienlstreated with high-dose cytarabine. Onco Targets Ther, 2011 , 4 :115-121.

共引文献66

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部